Colin Suckling

If you made any changes in Pure these will be visible here soon.

MGB Biopharma licensed to treat deadly infections
Colin Suckling (Participant), Iain Hunter (Participant), Alan Harvey (Participant), Simon MacKay (Participant) & Curtis G. Gemmell (Participant)
Impact: Impact - for External Portal › Economic and commerce, Health and welfare - new products, guidelines and services

File

Colin Suckling, OBE BSc PhD DSc CChem FRSC FRCS(Glasg) Hon FRCS (Edin) FRSA FRSE